IPCA LABORATORIES
Quarterly Results Analysis [Sep2024]
IPCA LABORATORIES Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹2,355 Cr | ₹2,093 Cr | ₹2,033 Cr | ₹2,053 Cr | ₹2,034 Cr | ₹1,585 Cr | ₹1,512 Cr | ₹1,546 Cr |
Expenses | ₹1,913 Cr | ₹1,700 Cr | ₹1,711 Cr | ₹1,722 Cr | ₹1,673 Cr | ₹1,277 Cr | ₹1,331 Cr | ₹1,330 Cr |
Operating Income | ₹441 Cr | ₹393 Cr | ₹322 Cr | ₹331 Cr | ₹361 Cr | ₹308 Cr | ₹181 Cr | ₹216 Cr |
Other Income | ₹26 Cr | ₹21 Cr | ₹19 Cr | ₹22 Cr | ₹39 Cr | ₹45 Cr | ₹36 Cr | ₹31 Cr |
Interest | ₹23 Cr | ₹24 Cr | ₹29 Cr | ₹33 Cr | ₹44 Cr | ₹31 Cr | ₹18 Cr | ₹11 Cr |
Depreciation | ₹100 Cr | ₹99 Cr | ₹98 Cr | ₹100 Cr | ₹90 Cr | ₹69 Cr | ₹70 Cr | ₹67 Cr |
Profit Before Tax | ₹345 Cr | ₹290 Cr | ₹77 Cr | ₹289 Cr | ₹225 Cr | ₹252 Cr | ₹129 Cr | ₹169 Cr |
Profit After Tax | ₹245 Cr | ₹199 Cr | ₹3 Cr | ₹223 Cr | ₹137 Cr | ₹166 Cr | ₹81 Cr | ₹116 Cr |
EPS | ₹9.05 | ₹7.58 | ₹2.35 | ₹7.09 | ₹5.72 | ₹6.42 | ₹3.02 | ₹4.25 |
Industry Peers & Returns | 1W | 1M | 1Y |
IPCA LABORATORIES | -0% | 1.8% | 48.7% |
SUN PHARMACEUTICAL INDUSTRIES | 1% | 4.6% | 47.5% |
CIPLA | -1.1% | -0.3% | 20.7% |
DR REDDYS LABORATORIES | 2.2% | 12.1% | 21.6% |
ZYDUS LIFESCIENCES | -2.7% | 0.8% | 43.8% |
DIVIS LABORATORIES | 1% | -3.2% | 59.3% |
MANKIND PHARMA | 0.8% | 12.8% | 52.4% |
TORRENT PHARMACEUTICALS | -1.5% | 5.9% | 55% |
LUPIN | 0.9% | 7.2% | 72.7% |
IPCA LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 12.53 % |
Y-o-Y | 15.78 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹2,355 Cr | 12.53 | |
Jun2024 | ₹2,093 Cr | 2.93 | |
Mar2024 | ₹2,033 Cr | -0.97 | |
Dec2023 | ₹2,053 Cr | 0.93 | |
Sep2023 | ₹2,034 Cr | 28.31 | |
Jun2023 | ₹1,585 Cr | 4.87 | |
Mar2023 | ₹1,512 Cr | -2.22 | |
Dec2022 | ₹1,546 Cr | - |
IPCA LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 12.42 % |
Y-o-Y | 22.44 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹441 Cr | 12.42 | |
Jun2024 | ₹393 Cr | 22.00 | |
Mar2024 | ₹322 Cr | -2.85 | |
Dec2023 | ₹331 Cr | -8.11 | |
Sep2023 | ₹361 Cr | 17.13 | |
Jun2023 | ₹308 Cr | 70.03 | |
Mar2023 | ₹181 Cr | -16.13 | |
Dec2022 | ₹216 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -0.11 % |
Y-o-Y | 5.75 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 18.75% | -0.11 | |
Jun2024 | 18.77% | 18.57 | |
Mar2024 | 15.83% | -1.92 | |
Dec2023 | 16.14% | -8.97 | |
Sep2023 | 17.73% | -8.70 | |
Jun2023 | 19.42% | 62.10 | |
Mar2023 | 11.98% | -14.18 | |
Dec2022 | 13.96% | - |
IPCA LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 23.35 % |
Y-o-Y | 78.58 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹245 Cr | 23.35 | |
Jun2024 | ₹199 Cr | 6,737.80 | |
Mar2024 | ₹3 Cr | -98.69 | |
Dec2023 | ₹223 Cr | 62.00 | |
Sep2023 | ₹137 Cr | -17.31 | |
Jun2023 | ₹166 Cr | 105.02 | |
Mar2023 | ₹81 Cr | -29.88 | |
Dec2022 | ₹116 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 9.57 % |
Y-o-Y | 54.14 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 10.42 % | 9.57 | |
Jun2024 | 9.51 % | 6,692.86 | |
Mar2024 | 0.14 % | -98.71 | |
Dec2023 | 10.85 % | 60.50 | |
Sep2023 | 6.76 % | -35.56 | |
Jun2023 | 10.49 % | 95.71 | |
Mar2023 | 5.36 % | -28.34 | |
Dec2022 | 7.48 % | - |
IPCA LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 19.39 % |
Y-o-Y | 58.22 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹9.05 | 19.39 | |
Jun2024 | ₹7.58 | 222.55 | |
Mar2024 | ₹2.35 | -66.85 | |
Dec2023 | ₹7.09 | 23.95 | |
Sep2023 | ₹5.72 | -10.90 | |
Jun2023 | ₹6.42 | 112.58 | |
Mar2023 | ₹3.02 | -28.94 | |
Dec2022 | ₹4.25 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD